Attention AACR Annual Meeting 2017 Registrants – Activate Your Access

Login for full access:

Username and password are not your MyAACR account information

Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

Conference Years:

Days Within Meeting:

Conferences:

Availability:

Participation Type:

Presentations Access:

Presentation Access:

Topic Tracks*:

Organ Site Tracks*:

  • Sort by:
  • Browse by:
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 193
Gene dysregulation in cancer: The view from chromosome neighborhoods
Richard A. Young
MIT Whitehead Inst. for Biomed. Research, Cambridge, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Histone modifications and gene expression in cancer
Scott A. Armstrong
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
ATP-dependent chromatin remodeling complexes in human cancer
Cigall Kadoch
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Enhancer reprogramming during cancer progression
Christopher R. Vakoc
Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States
from AACR Annual Meeting 2017 on April 1, 2017 8:00 AM-10:00 AM
Tumor treating fields added to standard chemotherapy in newly diagnosed glioblastoma (GBM): Final results of a randomized, multi-center, phase III trial
Roger Stupp
University Hospital Zurich & Northwestern University, Zurich & Chicago, Switzerland
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Phase I study of the alpha specific PI3-Kinase inhibitor BYL719 and the poly (ADP-Ribose) polymerase (PARP) inhibitor olaparib in recurrent ovarian and breast cancer: Analysis of the dose escalation and ovarian cancer expansion cohort
Panagiotis A Konstantinopoulos
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Targeting MUC16 with the THIOMABTM-drug conjugate DMUC4064A in patients with platinum-resistant ovarian cancer: a Phase I escalation study
Joyce F Liu
Dana-Farber Cancer Institute, Boston, MA, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Efficacy results based on PIK3CA status in BELLE-3: A Phase 3 study of buparlisib (BKM120) + fulvestrant in postmenopausal women with aromatase inhibitor-treated, HR+/HER2- ABC after progression on an mTOR inhibitor
Ruth O'Regan
University of Wisconsin Carbone Cancer Center, Madison, WI, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Circulating tumor DNA (ctDNA) sequencing for HER2 mutation (HER2mut) screening and response monitoring to neratinib in metastatic breast cancer (MBC)
Cynthia Ma
Washington University School of Medicine, St. Louis, MO, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Novel effect of tamoxifen therapy: disruption of ER-p53 interaction leading to altered gene expression profile in human breast tumors
Gokul M. Das
Roswell Park Cancer Inst., Buffalo, NY, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
NSABP FB-10: Phase Ib dose-escalation trial evaluating trastuzumab emtansine (T-DMI) with neratinib (N) in women with metastatic HER2+ breast cancer (MBC)
Jame Abraham
NSABP, and The Cleveland Clinic, Cleveland, OH, United States
from AACR Annual Meeting 2017 on April 2, 2017 3:00 PM-5:00 PM
Invited Speaker
A Thomas Look
Dana-Farber Cancer Inst., Boston, MA, United States
from AACR Annual Meeting 2017 on April 3, 2017 7:00 AM-8:00 AM
Invited Speaker
Dihua Yu
UT MD Anderson Cancer Ctr., Houston, TX, United States
from AACR Annual Meeting 2017 on April 3, 2017 7:00 AM-8:00 AM
Genetic heterogeneity and clonal evolution: Lessons from acute lymphoblastic leukemia
Charles G. Mullighan
St. Jude Children's Research Hospital, Memphis, TN, United States
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
Molecular heterogeneity through the life cycle of medulloblastoma
Michael D. Taylor
The Hospital for Sick Children, Toronto, ON, Canada
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
Genetic and nongenetic mechanisms of progression in pediatric solid tumors
Olivier Delattre
Institut Curie, Paris, France
from AACR Annual Meeting 2017 on April 3, 2017 1:00 PM-2:45 PM
Invited Speaker
Claudia Fischbach-Teschl
Cornell Univ., Ithaca, NY, United States
from AACR Annual Meeting 2017 on April 4, 2017 7:00 AM-8:00 AM
The cystine/glutamate anitporter (xCT): A new cancer stem cell target for anticancer vaccines
Federica Cavallo
Univ. of Turin, Turin, Italy
from AACR Annual Meeting 2017 on April 4, 2017 1:00 PM-2:45 PM
Vaccination in patients with low-grade glioma aiming at prevention of high-grade transformation
Hideho Okada
University of California, San Francisco, San Francisco, CA, United States
from AACR Annual Meeting 2017 on April 4, 2017 1:00 PM-2:45 PM
Antigens and vaccines for prevention of nonviral cancers
Olivera J. Finn
Univ. of Pittsburgh School of Medicine, Pittsburgh, PA, United States
from AACR Annual Meeting 2017 on April 4, 2017 1:00 PM-2:45 PM
Synthetic DNA vaccine technology for immuno-oncology applications
David Weiner
The Wistar Inst., Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 4, 2017 1:00 PM-2:45 PM
Invited Speaker
Dario C. Altieri
The Wistar Inst., Philadelphia, PA, United States
from AACR Annual Meeting 2017 on April 5, 2017 7:00 AM-8:00 AM
Engineering next-generation CAR T cells using synthetic biology-inspired technologies
Michael C Jensen
Seattle Children's Hospital, Seattle, WA, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
Defining the limitations of CD19CAR immunotherapy in pediatric ALL and development of effective countermeasures
Terry J Fry
National Cancer Institute, Bethesda, MD, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
Progress and challenges in CAR T cell therapy for brain tumors
Christine E. Brown
City of Hope, Duarte, CA, United States
from AACR Annual Meeting 2017 on April 5, 2017 10:15 AM-12:00 PM
<< first | < prev page: of 8 records per page: next > | last >>
pages: 1 2 3 4 5 6 7 8 presentations: 1 to 25 of 193